AV-101
AV-101 CL005
Phase 1 small_molecule active
Quick answer
AV-101 for Drug Drug Interaction is a Phase 1 program (small_molecule) at Vistagen Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vistagen Therapeutics
- Indication
- Drug Drug Interaction
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active